BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8760811)

  • 1. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
    Zheng LM; Ojcius DM; Garaud F; Roth C; Maxwell E; Li Z; Rong H; Chen J; Wang XY; Catino JJ; King I
    J Exp Med; 1996 Aug; 184(2):579-84. PubMed ID: 8760811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
    Kundu N; Beaty TL; Jackson MJ; Fulton AM
    J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
    Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
    Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.
    Hara I; Nguyen H; Takechi Y; Gansbacher B; Chapman PB; Houghton AN
    Int J Cancer; 1995 Apr; 61(2):253-60. PubMed ID: 7705956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
    Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
    J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages.
    Gillgrass A; Gill N; Babian A; Ashkar AA
    J Immunol; 2014 Dec; 193(12):6184-91. PubMed ID: 25355926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.
    Gorelik E; Wiltrout RH; Brunda MJ; Bere WE; Herberman RB
    Clin Exp Metastasis; 1985; 3(2):111-23. PubMed ID: 4042460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
    Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
    Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
    Buhtoiarov IN; Sondel PM; Eickhoff JC; Rakhmilevich AL
    Immunology; 2007 Mar; 120(3):412-23. PubMed ID: 17163960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18.
    Nagai H; Hara I; Horikawa T; Fujii M; Kurimoto M; Kamidono S; Ichihashi M
    Cancer Invest; 2000; 18(3):206-13. PubMed ID: 10754989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
    Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
    J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.